# Helm Operating Signal Flow Phase 3K DOM Evidence Harness Review Packet

## Conclusion

Phase 3K reviews the Phase 3J test-only DOM evidence harness and keeps the adoption boundary explicit.

Decision:

- **Go** for treating Phase 3J as sufficient internal component-contract regression evidence.
- **Conditional-Go** for a separate Phase 3L browser preview mechanism decision packet.
- **No-Go** for Storybook, hidden app route, `/operating` route adoption, browser screenshot harness implementation, runtime tenant data, schema, API, migration, production default query, official writes, auto-send, auto-approve, auto-execute, fixture banner removal, external side effects, or LLM final ranking.

This packet does not unlock a live preview surface. It only records that the test-only harness is enough to prove the internal readout component remains safe as a route-disconnected component contract.

## Evidence Reviewed

| Evidence | Result | Decision impact |
| --- | --- | --- |
| Phase 3J preview test | Chinese, English, and boundary-blocked states render in jsdom | Sufficient for component DOM contract regression |
| Guard attributes | `data-internal-readout-only`, `data-fixture-contract`, `data-production-truth="false"`, and `data-route-page-adoption="false"` are asserted | Keeps fixture / non-production posture explicit |
| Boundary-blocked case | Decision remains `stop` and routes to Security / Data Protection / Founder | Keeps high-risk path review-first |
| Raw-field scan | Serialized DOM rejects raw event IDs, trace IDs, request IDs, actor emails, and source pages | Keeps reviewer evidence alias-only / safe-field only |
| Interaction scan | No `a`, `button`, `form`, `input`, `textarea`, or `select` exists | No hidden write / send / approve affordance |
| Route import scan | `app/` and `/operating` still do not import the internal readout component or preview harness | No route or runtime UI adoption |
| Boundary guard | Only the exact test file was allowlisted | No broad boundary relaxation |
| Production health probe | `/health` returned `200` after the slice | Production stability unaffected |

## What Phase 3J Proves

Phase 3J proves only:

- the internal readout component can render sanitized reviewer states in a test-only DOM environment
- fixture and non-production guard attributes remain visible
- boundary-blocked readouts remain stop-first
- raw identifiers are not reflected into the rendered evidence
- the component still has no interaction surface
- route ownership remains unchanged

It does not prove:

- browser visual fit
- screenshot evidence
- responsive layout behavior
- user-visible preview readiness
- `/operating` adoption readiness
- runtime tenant data readiness
- production query readiness
- reviewer signoff for a live route

## Browser Preview Decision

Browser screenshot evidence remains **Not Applicable** in Phase 3K.

Reason:

- the repo has no approved non-route browser component preview mechanism
- existing Playwright coverage operates against app routes
- adding a hidden route would be route adoption by another name
- adding Storybook or a new component-preview runtime would introduce a new preview subsystem and must be separately reviewed

Therefore, the next safe step is not to implement browser preview. The next safe step is a decision packet that evaluates whether Helm should introduce a non-route browser component preview mechanism at all.

## Required Questions For Phase 3L

Any Phase 3L browser preview mechanism decision packet must answer:

| Question | Required posture |
| --- | --- |
| Does the repo need a reusable non-route browser component preview mechanism? | Decide before implementation |
| Can the mechanism avoid `app/` route adoption and hidden pages? | Required |
| Can it run without production data, DB reads, API routes, or env secret access? | Required |
| Can it keep screenshots alias-only and avoid raw DOM persistence? | Required |
| Can it be deleted without schema, DB, route, or production flag rollback? | Required |
| Will it be limited to reviewer evidence rather than user-facing product surface? | Required |
| Does it create any new public-release or boundary-check burden? | Must be explicitly assessed |

## Rollback Plan

Rollback remains delete-only:

- remove `features/internal-operating-workspace/operating-signal-flow-internal-readout.preview.test.tsx`
- remove the exact preview test allowlist entry from `scripts/decision-first-boundary-check.ts`
- remove Phase 3J / Phase 3K review docs and index lines
- keep Phase 3F helper and Phase 3G component untouched unless a separate defect is proven
- do not change `.env`
- do not run destructive database reset against a remote database
- do not toggle production runtime adoption flags

## Verification

Validated for this review packet:

```bash
npm run self-check
npm run check:public-release
npm run check:boundaries
npm run typecheck
npm run lint
npm run build
git diff --check
curl -fsS -o /tmp/helm-health-phase3k.txt -w '%{http_code}\n' <production-health-url>
```

Result:

- self-check passes
- public-release guard passes
- boundary gate passes
- typecheck passes
- lint passes
- build passes
- `git diff --check` passes
- production health probe returns `200`

Destructive database reset, e2e, and quality-regression are intentionally not part of Phase 3K because this slice is docs-only and does not change code, routes, schema, API, runtime, or production configuration.
